About: Rapid Deployment of a Free, Privacy-Assured COVID-19 Symptom Tracker for Public Safety During Reopening: System Development and Feasibility Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Rapid Deployment of a Free, Privacy-Assured COVID-19 Symptom Tracker for Public Safety During Reopening: System Development and Feasibility Study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Rapid Deployment of a Free, Privacy-Assured COVID-19 Symptom Tracker for Public Safety During Reopening: System Development and Feasibility Study
Creator	Sanchez, Travis Mircheva, Iskra Bridgeland, David Cederholm, John Dimolitsas, Spiros Kassaye, Seble Lau, Edwin Pandl, Konstantin Smart, JC Spence, Amanda
Source	Medline; PMC
abstract	BACKGROUND: Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the number of cases of coronavirus disease (COVID-19) in the United States has exponentially increased. Identifying and monitoring individuals with COVID-19 and individuals who have been exposed to the disease is critical to prevent transmission. Traditional contact tracing mechanisms are not structured on the scale needed to address this pandemic. As businesses reopen, institutions and agencies not traditionally engaged in disease prevention are being tasked with ensuring public safety. Systems to support organizations facing these new challenges are critically needed. Most currently available symptom trackers use a direct-to-consumer approach and use personal identifiers, which raises privacy concerns. OBJECTIVE: Our aim was to develop a monitoring and reporting system for COVID-19 to support institutions conducting monitoring activities without compromising privacy. METHODS: Our multidisciplinary team designed a symptom tracking system after consultation with experts. The system was designed in the Georgetown University AvesTerra knowledge management environment, which supports data integration and synthesis to identify actionable events and maintain privacy. We conducted a beta test for functionality among consenting Georgetown University medical students. RESULTS: The symptom tracker system was designed based on guiding principles developed during peer consultations. Institutions are provided access to the system through an efficient onboarding process that uses clickwrap technology to document agreement to limited terms of use to rapidly enable free access. Institutions provide their constituents with a unique identifier to enter data through a web-based user interface to collect vetted symptoms as well as clinical and epidemiologic data. The website also provides individuals with educational information through links to the COVID-19 prevention recommendations from the US Centers for Disease Control and Prevention. Safety features include instructions for people with new or worsening symptoms to seek care. No personal identifiers are collected in the system. The reporter mechanism safeguards data access so that institutions can only access their own data, and it provides institutions with on-demand access to the data entered by their constituents, organized in summary reports that highlight actionable data. Development of the system began on March 15, 2020, and it was launched on March 20, 2020. In the beta test, 48 Georgetown University School of Medicine students or their social contacts entered data into the system from March 31 to April 5, 2020. One of the 48 users (2%) reported active COVID-19 infection and had no symptoms by the end of the monitoring period. No other participants reported symptoms. Only data with the unique entity identifier for our beta test were generated in our summary reports. CONCLUSIONS: This system harnesses insights into privacy and data sharing to avoid regulatory and legal hurdles to rapid adaption by entities tasked with maintaining public safety. Our pilot study demonstrated feasibility and ease of use. Refinements based on feedback from early adapters included release of a Spanish language version. These systems provide technological advances to complement the traditional contact tracing and digital tracing applications being implemented to limit SARS-CoV-2 transmission during reopening.
has issue date	2020-08-13(xsd:dateTime)
bibo:doi	10.2196/19399
bibo:pmid	32788148
has license	cc-by
schema:url	https://doi.org/10.2196/19399
resource representing a document's title	Rapid Deployment of a Free, Privacy-Assured COVID-19 Symptom Tracker for Public Safety During Reopening: System Development and Feasibility Study
has PubMed Central identifier	PMC7431234
has PubMed identifier	32788148
schema:publication	JMIR Public Health Surveill
resource representing a document's body	covid:PMC7431234#body_text
is schema:about of	named entity 'PUBLIC' named entity 'FREE' named entity 'Feasibility Study' named entity 'Symptom' named entity 'HIPAA' named entity 'epidemiology' named entity 'Contact tracing' named entity 'monitoring systems' named entity 'Qualtrics' named entity 'Georgetown University' named entity 'health care worker' named entity 'quarantine' named entity 'symptom' named entity 'Deidentified' named entity 'contact tracing' named entity 'Georgetown University' named entity 'shortness of breath' named entity 'COVID' named entity 'COVID-19 in the United States' named entity 'quarantine' named entity 'Georgetown University' named entity 'Georgetown University' named entity 'beta test' named entity 'epidemiologic data' named entity 'SARS-CoV-2' named entity 'user interface' named entity 'contact tracing apps' named entity 'unstructured data' named entity 'fever' named entity 'Institutional Review Board' named entity 'United States' named entity 'asymptomatic' named entity 'beta testing' named entity 'infection' named entity 'knowledge management' named entity 'built-in safeguards' named entity 'occupational health' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'symptom' named entity 'Qualtrics' named entity 'social distancing' named entity 'COVID-19' named entity 'COVID-19 cases' named entity 'health status' named entity 'SARS-CoV-2' named entity 'infection' named entity 'public health' named entity 'COVID' named entity 'COVID-19' named entity 'contact tracing' named entity 'limited duration' named entity 'Georgetown University School of Medicine' named entity 'digital contact tracing' named entity 'morbidity' named entity 'COVID' named entity 'active COVID-19 cases' named entity 'home isolation' named entity 'SARS-CoV-2 pandemic' named entity 'beta test' named entity 'infection' named entity 'COVID' named entity 'COVID' named entity 'infection' named entity 'signs and symptoms' named entity 'contact tracing' named entity 'executable file' named entity 'School of Medicine' named entity 'follow-up' named entity 'epidemiology' named entity 'medical students' named entity 'occupational health' named entity 'infection' named entity 'COVID-19 infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software